ADVIA CENTAUR FOLATE (FOL) ASSAY N/A 06891541

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2014-01-10 for ADVIA CENTAUR FOLATE (FOL) ASSAY N/A 06891541 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[4075943] The customer observed an advia centaur folate (rbc) whole blood positive bias of approximately 30% when performing a reagent folate lot patient correlation study. Two additional advia centaur folate reagent lots were provided for repeat folate (rbc) whole blood patient correlation studies and a positive bias was also observed for each reagent lot. The customer also observed higher quality control recovery with folate whole blood (rbc) controls compared to peer quality control data, however, the results were within quality control product insert ranges. There was no known report of patient treatment being altered or adverse health consequences due to the advia centaur folate (rbc) whole blood higher patient results.
Patient Sequence No: 1, Text Type: D, B5


[11364059] The cause for the advia centaur folate (rbc) whole blood positive patient reagent lot bias and higher folate (rbc) quality control recovery compared to peer data is unknown and siemens is currently investigating. No conclusion can be drawn at this time.
Patient Sequence No: 1, Text Type: N, H10


[34904905] Siemens filed the initial mdr 1219913-2014-00005 on 01/10/2014 for an advia centaur folate whole blood cell positive patient and qc bias. On 04/09/2014 - additional information: based upon additional information and investigation, on march 25, 2014, siemens issued an urgent medical device recall (108180053) to its customers in the united states and an urgent field safety notice (10818055) to its customers outside of the united states, related to the advia centaur folate assay. Siemens has determined that the advia centaur systems folate assay, kit lots ending in 222, 224, 225, 226 and/or 227, meets the published claims in the ifu for normal whole blood cell folate. The whole blood cell folate results for lots ending in 219 may show a negative bias of up to 41. 2% relative to new lots 224, 225, 226, and 227. This negative bias may result in a patient receiving folate supplementation; however, this supplementation does not constitute a risk to health. The bio-rad lyphochek whole blood control lot 73210 insert control values were updated based on current unity peer data and internal confirmation testing. Bio-rad lyphochek whole blood control manufacturer updated qc insert values advia centaur /centaur xp: (b)(6).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2014-00005
MDR Report Key3569012
Report Source05,06
Date Received2014-01-10
Date of Report2013-12-03
Date of Event2013-12-03
Date Mfgr Received2014-03-18
Date Added to Maude2014-04-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. STEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Removal Correction Number1219913-03/25/2014-001-R
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR FOLATE (FOL) ASSAY
Generic NameFOLATE IMMUNOASSAY, PRODUCT CODE:
Product CodeCGN
Date Received2014-01-10
Model NumberN/A
Catalog Number06891541
Lot Number222, 223, 225
ID NumberN/A
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2014-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.